Preparation, characterization and properties of quercetin cyclodextrin nanosponges

被引:2
作者
Zhang, Wanping [1 ]
Gai, Houchen [1 ]
Zhang, Qianjie [1 ]
Zhang, Dongmei [1 ]
Zheng, Shilian [1 ]
Zhu, Guangyong [1 ]
机构
[1] Shanghai Inst Technol, 100 Haiquan Rd, Shanghai, Peoples R China
关键词
Cyclodextrin nanosponge; Quercetin; Characterization; Property; IN-VITRO; PHYSICOCHEMICAL CHARACTERIZATION; BIODEGRADABLE NANOPARTICLES; DIETARY FLAVONOIDS; ENCAPSULATION; DELIVERY; FORMULATION; STABILITY;
D O I
10.1007/s10847-024-01263-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Quercetin (QC) has various biological activities such as anti-inflammatory and antibacterial properties. However, due to its poor solubility and stability, the application of QC in clinical practice is limited. Nanosponge (NS), as a new drug carrier, can significantly improve the solubility of low-soluble drug components, and significantly improve the efficacy and bioavailability of drugs. In this paper, cyclodextrin nanosponges (CDNS) were synthesized by cross-linking beta-cyclodextrin with diphenyl carbonate (DPC) in a green and safe synthetic pathway. As wall material, CDNS were further used to encapsulate quercetin and quercetin-cyclodextrin nanosponges (QCNS) were formed. The resultant CDNS and QCNS were characterized by scanning electron microscopy, infrared spectroscopy, X-ray diffraction, and thermogravimetric analysis. The results showed that CDNS and QCNS were successful prepared. The solubilizing impact of CDNS on quercetin was investigated. The results showed that its solubility in water was 176 times higher than that of pure QC. The cumulative release of quercetin and QCNS over 48 h and the cumulative transdermal penetration over 12 h were measured. The antioxidant and antibacterial properties of QCNS were determined. QCNS exhibited superior stability, permeability, and sustained-release properties compared to pure quercetin, and had notable bacteriostatic and antioxidant capabilities.
引用
收藏
页码:23 / 34
页数:12
相关论文
共 29 条
  • [1] Optimization of microwave-assisted synthesis of cyclodextrin nanosponges using response surface methodology
    Anandam, Singireddy
    Selvamuthukumar, Subramanian
    [J]. JOURNAL OF POROUS MATERIALS, 2014, 21 (06) : 1015 - 1023
  • [2] Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
    Ansari, Khalid A.
    Vavia, Pradeep R.
    Trotta, Francesco
    Cavalli, Roberta
    [J]. AAPS PHARMSCITECH, 2011, 12 (01): : 279 - 286
  • [3] Bergal A., 2021, ACTA PHARM SCI, V59, P306, DOI [10.23893/1307-2080.aps.05918, DOI 10.23893/1307-2080.APS.05918]
  • [4] Cyclodextrin-based nanosponges for drug delivery
    Cavalli, Roberta
    Trotta, Francesco
    Tumiatti, Wander
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2006, 56 (1-2) : 209 - 213
  • [5] Synthesis and spectral investigation of Al(III) catechin/β-cyclodextrin and Al(III) quercetin/β-cyclodextrin inclusion compounds
    Dias, Karina
    Nikolaou, Sofia
    De Giovani, Wagner F.
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2008, 70 (01) : 154 - 161
  • [6] Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery
    Guo Chen-yu
    Yang Chun-fen
    Li Qi-lu
    Tan Qi
    Xi Yan-wei
    Liu Wei-na
    Zhai Guang-xi
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 430 (1-2) : 292 - 298
  • [7] Dietary flavonoids: Intake, health effects and bioavailability
    Hollman, PCH
    Katan, MB
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (9-10) : 937 - 942
  • [8] Kelly GS, 2011, ALTERN MED REV, V16, P263
  • [9] Analytical tools for cyclodextrin nanosponges in pharmaceutical field: a review
    Kumar, Sunil
    Rao, Rekha
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2019, 94 (1-2) : 11 - 30
  • [10] Encapsulation of Babchi Oil in Cyclodextrin-Based Nanosponges: Physicochemical Characterization, Photodegradation, and In Vitro Cytotoxicity Studies
    Kumar, Sunil
    Pooja
    Trotta, Francesco
    Rao, Rekha
    [J]. PHARMACEUTICS, 2018, 10 (04):